Saturday, January 17, 2026
name of Prensa Latina
Bandera inglesa
English Edition
Search
Close this search box.
name of Prensa Latina

NEWS

SCIENCES

Rome, Jun 7 (Prensa Latina) Cuban Neuroscientist Mitchell Valdés Sosa, director of the Cuban Neurosciences center (CNEURO, in Spnaish) and Dr. Vicente Vérez, director of the Finlay Institute of Vaccines (IFV, in Spanish), on Tuesday claimed their visits to Italy help to strengthen experience, development and cooperation with Italian specialists.
Washington, Apr 11 (Prensa Latina) A group of researchers have successfully minimized artery-narrowing plaque in mice and, if applied to humans, this could prevent atherosclerosis, one of the causes of heart attacks and strokes.
Madrid, Apr 11 (Prensa Latina) A newborn must develop in a clean environment but without excesses, since he must interact with microbes in the environment to strengthen his immune system, a specialized source revealed on Monday.
Washington, Apr 5 (Prensa Latina) Researchers have identified a family of proteins that is significantly elevated in the saliva of patients hospitalized with Covid-19. The proteins, known as ephrin ligands, could potentially serve as a biomarker to help doctors identify patients who are at risk for serious illness.
Madrid, Apr 1 (Prensa Latina) Promptness, an adequate assessment of patient's situation and personalized treatment are key elements to treat Aphasia (a health problem caused by stroke), a specialized source revealed Friday.
Washington, Apr 1 (Prensa Latina) A group of specialists reiterated their deep concern about cannabis use in pregnant women, who may give birth to underweight children, among other consequences, a specialized source revealed on Friday.
Washington, March 31 (Prensa Latina) Researchers from the Scripps Institution of Oceanography at the University of California in San Diego, United States, revealed that a marine bacterium produces a powerful anti-cancer molecule, a scientific publication reported Thursday.
Washington, March 31(Prensa Latina) Researchers at the George Washington University published findings from the world's largest cohort study showing that hospitalized patients with moderate Covid-19 who were given aspirin early on in their treatment had a lower risk of dying compared to patients who were not given aspirin.